Virginkar Discusses Ruling on Attorney-Client Privilege in Manafort Money-Laundering Case
November 3, 2017
Global Investigations Review
Partner Rohan Virginkar is quoted in a Global Investigations Review article, “A Rare Ruling in Manafort Case Highlights Privilege limitations,” about a judge’s ruling that Special Counsel Robert Mueller’s team can question a former lawyer for President Trump’s ex-campaign manager, Paul Manafort, and his business partner, Richard Gates, about letters she submitted to the U.S. Department of Justice on their behalf under the Foreign Agents Registration Act.
Virginkar said the language in the judge’s opinion reinforces the reality that attorney-client privilege is narrowly interpreted in criminal investigations.
“Many discussions between lawyers and clients that relate to disclosures that will be made – including, like here, to the government – may not be covered by privilege,” he said, adding, “In many cases you will still have the work product protections as a back-stop to prevent disclosure.”
Virginkar said the language in the judge’s opinion reinforces the reality that attorney-client privilege is narrowly interpreted in criminal investigations.
“Many discussions between lawyers and clients that relate to disclosures that will be made – including, like here, to the government – may not be covered by privilege,” he said, adding, “In many cases you will still have the work product protections as a back-stop to prevent disclosure.”
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."